Latest Johnson & Johnson News
Johnson & Johnson: Q4 Earnings Snapshot
NEW BRUNSWICK, N.J. (AP) — NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Wednesday reported fourth-quarter profit of $3.43 billion. The New Brunswick, New Jersey-based company said it had net income of $1.41 per share. Earnings, adjusted for non-recurring costs and...
Stock market today: Gains for oil producers and drops for Big Tech leave Wall Street mixed
NEW YORK (AP) — U.S. stock indexes were split on Monday as gains for oil-and-gas producers helped offset drops for Nvidia and other Big Tech companies. The S&P 500 rose 0.2% after erasing an earlier fall of 0.9%. The Dow Jones Industrial Average climbed 358 points, or 0.9%,...
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said Monday that it will pay $132 in cash for each share of Intra-Cellular. That represents a...
FDA proposes new testing rules to ensure cosmetics are asbestos-free
WASHINGTON (AP) — Cosmetic companies would have to take extra steps to ensure that any products containing talc are free of asbestos under a federal rule proposed Thursday. The proposal from the Food and Drug Administration and mandated by Congress is intended to reassure consumers...
FDA says decongestant in many cold medicines doesn't work. So what does?
WASHINGTON (AP) — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, concluding that it doesn’t actually relieve nasal congestion. Phenylephrine is...
